PCN64 Evaluating the Cost-Effectiveness of the Addition of Rituximab to Chemotherapy in the First Line Treatment of Follicular Lymphoma Patients in the UK
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1165
https://www.valueinhealthjournal.com/article/S1098-3015(11)02727-6/fulltext
Title :
PCN64 Evaluating the Cost-Effectiveness of the Addition of Rituximab to Chemotherapy in the First Line Treatment of Follicular Lymphoma Patients in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02727-6&doi=10.1016/j.jval.2011.08.1165
First page :
A445
Section Title :
Cancer
Open access? :
No
Section Order :
1122